Attendance by day
scroll down
Forum in
numbers
Forum participation
Forum attendance
75
countries represented
1425
participants attended the Forum



2252
registrations
44% (122)
of the 275 presenters were female
270
abstract-based presentations
54
sessions in Forum programme



Forum programme

Attendance by type
39

18

9

2

3

4

85
1340
360
502
678
854
317
Number of countries represented

Note:
A further €110.47M for 246 grants was awarded to projects on non-intervention-specific topics.
*EDCTP grants only
By intervention
Note:
A further €58.01M for 153 grants was awarded to projects on non-disease-specific topics.
*EDCTP grants only
**EDCTP. grants only
Portfolio of grants by disease
2003-2018
EDCTP’s investment
in research & development

In 192 projects awarded by end of 2018
€447.04 M
Total funding





17
EDCTP African member countries participated in a survey to inform the development of a strategic policy plan for strengthening health research systems capacities of countries in sub-Saharan Africa. This project is a joint initiative between EDCTP and WHO-AFRO.
3
grant consortia were established through an EDCTP call to support health systems/service optimisation research capacities in cooperation with development assistant’. Two of these consortia received funding from international development cooperation
partners (SIDA and USAID).
68
private sector entities are involved in EDCTP projects. By end of 2018 , these organisations have received €49.42 M in grant value.
External partnerships
Increase interaction with other EU initiatives, including those linked to development assistance.

60%
of the total EDCTP grant value is allocated to sub-Saharan African institutions (€186 million).
60%
of the total EDCTP grant value is allocated to sub-Saharan African institutions (€186 million).
162
private sector entities are involved in EDCTP projects. By end of 2019, these organisations have received €89.26 million in grant value.
16
sub-Saharan African countries are full members of the EDCTP Association. These members have contributed to a total of €1.21 million by end of 2018 through the Participating States’ Initiated Activities (PISIAs) – research activities within the scope of the EDCTP programme that are funded and implemented by one or more member countries.
External partnerships
Increase international cooperation with public
and private partners.

€158.8 M
total cash received from the European Participating States to the EDCTP programme.
14
European countries are members of the EDCTP Association.
European coordination
Improve coordination alignment and integration of
European National Programmes.

7,488
people have participated in EDCTP project-related training and workshops on topics such as study protocol development, specimen collection, research and administration, Good Clinical Practice and epidemic preparedness.
16
sub-Saharan African countries are members of the EDCTP Association. By end of 2019, these members have submitted 120 Participating States’ Initiated Activities (PSIAs) of total committed value of €67 million.
€23.43 M
has been invested to support preparedness of 6 sub-Saharan African countries in the ght against Ebola
outbreaks.
89
fellowships that focus on the career development of researchers.
37
sub-Saharan African countries participate in EDCTP projects involving 208 sub-Saharan African organisations. These account for 57.6% of total EDCTP funding.
27
sub-Saharan African countries have received EDCTP support for the establishment of functional regulatory systems and capacities for ethical review of clinical research.
Collaboration and capacity development
Increase cooperation
with sub-Saharan Africa through capacity building for conducting clinical trials according to ethical principles and regulatory standards

32
Sub-Saharan Africa countries hosts recruitment sites of EDCTP-funded collaborative clinical studies.
15%(18)
of the large-scale clinical studies involve post-licensing (phase IV) studies with a view to influencing health policies and practice and optimising the delivery of medical interventions for the wide-range of sub-Saharan African health systems and diverse populations.
10%(121)
of all studies target pregnant women and their children. Other key populations are also involved in the studies, such as newborns and infants (35; 17%), children (64; 31%) and adolescents (60; 29%).
217
the total number of clinical studies supported by EDCTP2 since 2014. Of these, 59% (130) are interventional (clinical trials) and 41% (87) are non-interventional studies.
57%(71)
are phase II and III trials of drugs and vaccines which aim to deliver key evidence on safety and efficacy, as well as provide data to support product registration.
Medical interventions
New or improved medical interventions against
poverty-related infectious diseases.
Towards
EDCTP2’s
objectives
